cardiovascular diseases

  2. cardiovascular diseases

VASCULAR DEPRESSION AND CARDIOVASCULAR COMPLICATIONS OF TYPE 2 DIABETES

Kostrikova U. A., Myakinkova L. O., Pustovoit G. L., Yarmola T. I.
2023 Issue 1, 168 cardiovascular diseases depression diabetes mellitus vascular endothelial regulation vasoactive substances

CALCIUM ANTAGONIST AMLODIPINE AND PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES (LITERATURE REVIEW)

Kovtoniuk D. M.
2024 Issue 1, 172 amlodipine arterial hypertension calcium antagonists cardiovascular diseases

ANALYSIS OF COMORBIDITY IN COMMUNITY-ACQUIRED PNEUMONIA ASSOCIATED WITH COVID-19

Chaban I. V., Marushchak M. I.
2024 Issue 2, 173 arterial hypertension cardiovascular diseases COVID-19 pneumonia prevalence

POTENTIAL CORRELATION OF VASPIN EXPRESSION WITH RESISTANCE AND COMBINED EXERCISES IN WOMEN WITH THE METABOLIC SYNDROME

Ustimenko Y. A., Mazur Iu. Iu.
2024 Issue 4, 175 cardiovascular diseases combined exercises metabolic syndrome resistance exercises type 2 diabetes vaspin

AORTIC DIMENSION BY COMPUTED TOMOGRAPHY AND CORRELATION WITH ANTHROPOMETRIC PARAMETERS IN HEALTHY WOMEN

Pidvalna U. Ye., Beshley D. M., Harapko T. V., Golovatskii A. S., Mateshuk-Vatseba L. R.
2024 Issue 4, 175 age anthropometry aorta ascending aorta cardiovascular diseases correlation diameter

CAFFEINE EFFECT ON ECHOCARDIOGRAPHY PARAMETERS IN RATS WITH DOXORUBICIN-INDUCED CARDIOMYOPATHYS

Mukvych V. V., Severynovska O. V.
2025 Issue 1, 176 cardiotoxicity cardiovascular diseases effect of stimulants organism oxidative stress Pharmacology

JUSTIFICATION OF THE CONCEPTUAL, FUNCTIONAL, AND ORGANIZATIONAL MODEL OF THE REGIONAL CARDIAC CARE SYSTEM FOR THE ADULT POPULATION

Ivaniuk A. V.
2025 Issue 1, 176 and organizational model cardiac care system cardiovascular diseases conceptual functional